Company Filing History:
Years Active: 2025
Title: Mei Xia: Innovator in Pharmaceutical Patents
Introduction
Mei Xia is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and formulations. With a total of 2 patents, her work focuses on addressing critical health issues.
Latest Patents
Mei Xia's latest patents include innovative formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile. This patent provides polymorphs and formulations aimed at treating ocular surface pain and offers methods for treating dry eye disease and ocular hyperemia. Additionally, she has developed NLRP3 inflammasome inhibitors, which are novel pyridazin-3-yl phenol compounds that inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. These inventions are crucial for the treatment of diseases mediated by NLRP3.
Career Highlights
Throughout her career, Mei Xia has worked with notable companies such as Novartis AG and Bausch + Lomb Ireland Limited. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Mei Xia has collaborated with esteemed colleagues, including Xiaobin Ge and Henri Mattes. These partnerships have fostered an environment of innovation and have led to the successful development of her patented inventions.
Conclusion
Mei Xia's contributions to the pharmaceutical field through her patents and collaborations highlight her role as a leading inventor. Her work continues to impact the treatment of various health conditions, showcasing her dedication to innovation in medicine.